PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

Autor:	MA Espinoza, T. Abbott, C. Balmaceda
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Chemotherapy business.industry Health Policy medicine.medical_treatment Public Health Environmental and Occupational Health Budget impact chemistry.chemical_compound chemistry Obinutuzumab Internal medicine medicine Hodgkin lymphoma Rituximab business medicine.drug
Zdroj:	Value in Health. 23:S15
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::acb0678770a03ce5beab8648c1a9a35e https://doi.org/10.1016/j.jval.2020.04.078 Zobrazit plný text záznamu Full Text from ScienceDirect